Abstract:Objective: To assess the efficacy of magnetic resonance imaging (MRI)-directed ultrasound (US) in further characterizing lesions detected on MRI and to evaluate the correlation between lesion characteristics and their visibility on US. Methods: A retrospective review was performed of the records of patients with breast abnormalities detected on MRI between May 2018 and December 2020. All patients who were given a Breast Imaging-Reported and Data System Assessment Category 4 or 5 on breast MRI and sent to breast US for assessment of the MRI abnormality were included. Patients lost to follow-up or those who did not get their subsequent ultrasound at our institution were excluded. The following factors were recorded for all lesions described on the MRI reports: breast density, degree of background parenchymal enhancement, type of MRI finding (mass, areas of non-mass enhancement [NME], enhancing focus), largest dimension, T2 signal intensity, kinetics, shape, margins, enhancement pattern, and presence of ipsilateral breast malignancy. For the subset of the lesions that were identified on MRI-directed US, we recorded the following sonographic features: largest dimension, shape, and margin. The chi-square or Fisher exact tests of association were used to compare categorical characteristics. Results: Two hundred and thirty-three MRI-detected breast lesions were included in the study, which consisted of 171 masses, 7 enhancing foci, and 55 NME lesions. Of all lesions, 52% (89/171) of masses, 29% (16/55) of areas of NME, and 29% (2/7) of foci were seen on US. Moreover, 43 per 63 (68%) of malignant, 18 per 47 (38%) of high-risk and 46 per 123 (37%) of benign lesions were seen on MRI-directed US. Of the invasive malignant lesions, 77% (36/47) had a sonographic correlate. For masses, the average size on MRI was 1.1 cm, and MRI size had a statistically significant association with US visibility (P value 0.01). Similarly, spiculated margins on MRI for masses had a significant association with US visibility (P value 0.0006). Linear, segmental, and regional distributions of areas of NME were associated with decreased likelihood of sonographic visibility (P = 0.049). Conclusion: MRI-directed US is a useful tool in the management of MRI-detected breast lesions. Our study indicates that masses, particularly those with spiculated margins on MRI, should be sent to US for further assessment. Additionally, masses are more likely to be seen under US as their size increases. MRI-directed US is less likely to visualize areas of NME and enhancing foci, which may be managed with MRI follow-up or MRI-guided biopsy depending on their level of suspicion.

Diagnostic Evaluations of Ultrasound and Magnetic Resonance Imaging in Mammary Duct Ectasia and Breast Cancer

Ultrasound Elastography and Magnetic Resonance Examinations Are Effective for the Accurate Diagnosis of Mammary Duct Ectasia

Can Combined Screening of Ultrasound and Elastography Improve Breast Cancer Identification Compared with MRI in Women with Dense Breasts-a Multicenter Prospective Study

MR Imaging Evalution of Ductal Carcinoma in Situ and Ductal Carcinoma in Situ with Small Invasive Foci of Breast

Diagnostic Efficacy of Contrast-Enhanced Ultrasound for Breast Lesions of Different Sizes: a Comparative Study with Magnetic Resonance Imaging.

Comparison between combined ultrasounds and magnetic resonance imaging in the differentiation of benign and malignant breast lesions: a cross-sectional study

Value of Ultrasound Elastography Combined with Contrast-Enhanced Ultrasound and Micro-Flow Imaging in Differential Diagnosis of Benign and Malignant Breast Lesions.

Diagnostic Efficacy of Contrast-Enhanced Sonography by Combined Qualitative and Quantitative Analysis in Breast Lesions A Comparative Study with Magnetic Resonance Imaging

Efficacy of MRI-Directed Breast Ultrasound and Lesion Characteristics Affecting Visualization on Breast Ultrasound

Differentiating Benign from Malignant Solid Breast Lesions: Combined Utility of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Comparison with Magnetic Resonance Imaging.

Diagnostic Value of Ultrasound Elastography in the Differentiation of Breast Invasive Ductal Carcinoma and Ductal Carcinoma in Situ.

Diagnostic performance of contrast-enhanced ultrasound and enhanced magnetic resonance for breast nodules

Diagnostic value of mammography combined with ultrasound shear wave elastography and magnetic resonance imaging in breast cancer

Preoperative Assessment of Extrathyroidal Extension of Papillary Thyroid Carcinomas by Ultrasound and Magnetic Resonance Imaging: a Comparative Study

The Diagnostic Value of Dedicated Breast Magnetic Resonance Imaging in Breast Cancer: Comparative Study with Digital Mammography and Ultrasound

Diagnostic Efficacy of Contrast-Enhanced Ultrasound Enhancement Patterns and Quantitative Analysis in Breast Lesions: Comparison with Contrast-enhanced MRI

Multimodal ultrasound assessment of mass and non-mass enhancements by MRI: Diagnostic accuracy in idiopathic granulomatous mastitis and breast cancer

Comparative Study of Contrast-Enhanced Ultrasound and MRI Used in Breast Intraductal Lesions

Comparison of the Diagnostic Value of Contrast-Enhanced Ultrasound Combined with Conventional Ultrasound Versus Magnetic Resonance Imaging in Malignant Non-Mass Breast Lesions

Comparative Study of the Diagnostic Value of Ultrasonography and MRI in Mucinous Adenocarcinoma of Breast

Diagnostic evaluation of ductal carcinoma in situ of the breast: ultrasonographic, mammographic and histopathologic correlations